Northrop Grumman enters August with a notable tension: the stock is essentially flat on the week while several close defense peers have posted meaningful gains, and a wave of post-earnings analyst target cuts has pushed consensus estimates below recent trading levels.
The analyst story is the clearest thing to focus on here. The direction of travel since mid-July has been unmistakably downward. JP Morgan cut its target to $600 from $635, TD Cowen trimmed to $550 from $580, and Goldman Sachs moved to $533 from $603 — all while holding neutral or hold ratings. Susquehanna delivered the sharpest revision, dropping its target to $655 from $785, though it kept a positive rating. Against that, UBS was the lone dissenter, nudging its buy-rated target up to $685 from $666. The net result: a consensus mean target near $643, implying roughly 16% upside from the current $551.55 — meaningful in theory, but the trajectory of those estimates has been heading in the wrong direction. The stock does retain genuine long-cycle support in the bull case: programs like B-21, F/A-XX, and Golden Dome are expected to sustain contract flow into 2027 and beyond. Bears point the other way, flagging space segment softness, program realignment headwinds, and management's prioritisation of reinvestment over buybacks.
Short interest is a non-story here. At 1.66% of the free float — up about 9% over the past month but still a modest absolute level — there is no meaningful short-side pressure. Borrow availability is essentially unlimited, with over 141 million shares available to lend against roughly 2.4 million sold short, and cost to borrow is running near 0.40%, barely above risk-free. The borrow market offers no signal in either direction. Options positioning is similarly subdued: the put/call ratio is 1.09, only modestly above its 20-day average of 1.05 and well within normal range. None of the derivatives or lending data points to anything unusual building ahead of the October 29 earnings date.
The peer comparison is more telling than the short data. LHX fell 6.5% on the week. HII gained 7.7%. LMT added 1.4%. NOC itself moved less than half a percent. That divergence tracks a broader pattern flagged in recent notes: NOC has been a consistent underperformer within the group year-to-date, with the gap explained less by aggressive short positioning and more by company-specific execution concerns around its space segment. Institutional flows are broadly stable — Capital Research remains the largest holder at roughly 11% of shares, and Wellington added over 2 million shares as of the June quarter-end — so the drift lower looks like valuation compression rather than forced selling.
The Q1 print in late July produced a modest positive reaction, with the stock rising 3.2% on the day and holding a small gain over the following five sessions. The next event to watch is Q3 earnings on October 29. Between now and then, the setup is defined less by short positioning or borrow tightness and more by whether the analyst consensus stabilises — or whether another round of target reductions follows any further programme news out of the space segment.
See the live data behind this article on ORTEX.
Open NOC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
